Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Joincare Pharmaceutical Group Industry Co (SHSE:600380) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Joincare Pharmaceutical Group Industry Co PEG Ratio Related Terms
Joincare Pharmaceutical Group Industry Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Joincare Pharmaceutical Group Industry Co PEG Ratio Chart
Joincare Pharmaceutical Group Industry Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Joincare Pharmaceutical Group Industry Co PEG Ratio vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Joincare Pharmaceutical Group Industry Co (SHSE:600380) has a PEG Ratio of 2.19 as of Aug. 13, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors. This is 67% above median its historical median of 1.31. Over the past decade, Joincare Pharmaceutical Group Industry Co's PEG Ratio has ranged from 0.11 to 9.16. According to the industry distribution chart, Joincare Pharmaceutical Group Industry Co ranks #195 out of 345 companies in the Drug Manufacturers industry, placing it in the top 56.5%.
Is Joincare Pharmaceutical Group Industry Co's PEG Ratio too high?
Joincare Pharmaceutical Group Industry Co's current PEG Ratio of 2.19 is 67% above median its 10-year median of 1.31. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 9.16. The Drug Manufacturers industry median PEG Ratio is 1.78. Joincare Pharmaceutical Group Industry Co's value of 2.19 is 23% above this industry median. Based on the distribution chart, Joincare Pharmaceutical Group Industry Co ranks #195 out of 345 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Joincare Pharmaceutical Group Industry Co has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Joincare Pharmaceutical Group Industry Co's PEG Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Joincare Pharmaceutical Group Industry Co ranks #195 out of 345 companies for PEG Ratio. This places Joincare Pharmaceutical Group Industry Co in the lower half of its industry. The industry median PEG Ratio is 1.78. Joincare Pharmaceutical Group Industry Co's value of 2.19 is 23% above this benchmark. Historically, Joincare Pharmaceutical Group Industry Co's own PEG Ratio has ranged from 0.11 to 9.16 over the past decade. While the company's 10-year median is 1.31 vs. the industry median of 1.78, Joincare Pharmaceutical Group Industry Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.78, based on 345 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Joincare Pharmaceutical Group Industry Co's current PEG Ratio of 2.19 is 23% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Joincare Pharmaceutical Group Industry Co's current PEG Ratio is 2.19, which is 67% above median its own 10-year median of 1.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joincare Pharmaceutical Group Industry Co stock overvalued right now?
Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co (SHSE:600380) is currently considered Fairly Valued. The stock's GF Value™ is ¥11.11, compared to a current price of ¥10.42 — trading 6.2% below its estimated fair value. The current PEG Ratio is 2.19, which is 67% above median its 10-year median of 1.31 and 23% above the Drug Manufacturers industry median of 1.78. Joincare Pharmaceutical Group Industry Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Joincare Pharmaceutical Group Industry Co (SHSE:600380), the current PEG Ratio is 2.19 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Joincare Pharmaceutical Group Industry Co (SHSE:600380) Overvalued in 2026?
Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co stock appears to be undervalued.
The current stock price of ¥10.42 is trading 6.2% below its estimated GF Value™ of ¥11.11.
GuruFocus considers Joincare Pharmaceutical Group Industry Co to be Fairly Valued.
Key valuation signals for SHSE:600380:
PEG Ratio: 2.19 (67% above median its 10-year median of 1.31)
GF Value™: ¥11.11 vs. price of ¥10.42 (6.2% below fair value)
Industry Position: 23% above the Drug Manufacturers median (#195 of 345)
No single metric tells the full story. See the SHSE:600380 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
80GF Score
Get the complete analysis for SHSE:600380
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600380 has been successfully added to your 
